Research / Academic
We are offering a research position for a highly motivated Postdoc to study the epigenetic differences in neuroblastoma. Neuroblastoma is a pediatric tumor with often a fatal outcome. Primary tumors go in complete remission upon therapy, but relapse as resistant disease. At the department of Oncogenomics we study relapse mechanisms by high throughput-, bioinformatic- and cell biology- technologies. We found that neuroblastoma consist of two phenotypically divergent types of tumor cells (van Groningen et al., Nature Genetics 2017). They share the same genetic defects and can transdifferentiate into one another. They also have highly divergent epigenetic landscapes, including different super enhancers and core regulatory circuitries. One of the cell types is more therapy-resistant and may cause relapses. In this project funded by the Netherlands Cancer Foundation, we will clarify the epigenetic mechanisms underlying the trans-differentiation between the two cell types and their deregulation in cancer. You will apply screening technologies with in vitro trans-differentiation models, chromatin analyses and protein-protein interactions of chromatin modifiers and collaborate with the bioinformatics team in the for bioinformatic analyses. Effects of drugs intervening with epigenetic modification will be tested.
- Continuation of a research line funded by the Netherlands Cancer Foundation.
- Analyze high-throughput data including RNA-seq, ChIP-seq and whole genome sequencing and extract new ideas.
- Set up the protocol and analysis for proteomics related to epigenetic modifiers.
- Select and screen epigenetic inhibitors and test in a model system.
- We are looking for an ambitious postdoc with an interest in epigenetic regulation.
- You have obtained a PhD in molecular or cancer biology.
- You are analytical and creative.
- Experience in molecular biology, cell culture and protein-protein interaction techniques is required.
- Experience with analysis of high-throughput data (e.g. expression arrays, RNA-seq and ChIP-seq) is an advantage, but we are supported by a strong bioinformatics team (head Dr. Jan Koster).
- Good communication skills in English is required.
- A jump start to your career in research work.
- All te space for you to contribute shaping the care of tomorrow.
- Working on large-scale and research project, with motivated colleagues from all over the world.
- We offer a contract for a year (12 months) with the intention to extend for a term with a maximum of the project duration (2 years).
- Additional benefits include an 8.3% end-of-year bonus and 8.0% holiday pay.
- The base salary does not include holiday pay (8%) and a year-end bonus (8.3%).
- In addition to excellent accessibility by public transport, AMC also has a sufficient number of parking spaces for employees.
- Pension is accrued at Be Frank.
36 hours per week
Read more here: Source link